This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
By Rossella De Falco Strong, well-coordinated and resilient publichealth care services play a vital role in preventing and responding to publichealth crises. What are, however, the specific legal and ethical implications of involving private actors in health care vis-à-vis publichealth emergencies?
Extensive abuses of human rights during the pandemic led international experts to draft the Principles and Guidelines on Human Rights and PublicHealth Emergencies (HR Principles). The inadequacy of Siracusa in the the context of publichealth emergencies Then came COVID-19.
While receiving significant global traction and acceptance since their publication in 1985, the Siracusa Principles, the authors argue, proved to be simply “unequal to the task” of guiding States’ conduct in the context of COVID-19 because they are “unable to speak in any significant detail to the particular concerns of publichealth crises.”
An estimated 500,000 patents were pledged under the Open COVID Pledge, with over a million more pledged under a similar Japanese effort. Like the Open COVID Pledge before it, Moderna’s pledge expressly states that it is valid only “ while the pandemic continues. Pfizer made such a vaccine. Moderna’s Pledge.
By Roojin Habibi, Timothy Fish Hodgson, and Alicia Ely Yamin Today, as the world transitions from living in the grips of a novel coronavirus to living with an entrenched, widespread infectious disease known as COVID-19, global appreciation for the human rights implications of publichealth crises are once again rapidly fading from view.
It has been an important forum for enabling States to address the fault lines in national publichealth systems, bridge gaps in global health security and policy, and strengthen collective efforts to build back better. Supply chains must be strengthened, diversified, and kept open during publichealth emergencies.
By Calvin Wai-Loon Ho With the mainstreaming of digital technology across many spheres of social life, infodemic management must be an integral part of publichealth emergency prevention, preparedness, response, and recovery.
By Kayum Ahmed, Julia Bleckner, and Kyle Knight In mid-May, the WorldHealth Organization officially declared the “emergency” phase of the COVID-19 pandemic over. Publichealth emergencies aren’t entirely preventable. Solidarity operates at two intersecting levels.
To allocate COVID-19vaccines, the CDC’s Advisory Committee on Immunization Practices , the National Academies of Sciences, Engineering and Medicine (NASEM), and the WorldHealth Organization (WHO) identified ethical goals for prioritization, such as maximizing benefit and minimizing harm, mitigating health inequities, and reciprocity.
can take a bigger step to promote global publichealth now. has offered to share technology associated with National Institutes of Health inventions to a WHO pool of patents. Current vaccine and treatment inequity was not inevitable. This is consistent with TRIPS flexibility to disclose such data.
Two pharmaceutical giants of the pandemic, Moderna and BioNTech, are taking steps for increasing the manufacturing capacity for the COVID-19vaccine in Africa. Last March, Moderna announced its plan to set up a manufacturing facility in Kenya to produce messenger RNA (mRNA) vaccines, including COVID-19 shots.
By Tara Davis and Nicola Soekoe In January 2021, the Director General of the WorldHealth Organization (WHO) observed that the world was on the brink of a “catastrophic moral failure” if wealthier nations did not ensure the equitable distribution of COVID-19vaccines.
Vaccines are pharmaceutical products, a critical tool in public and global health. At the same time, they are regularly treated as commodities , often in ways that are completely divorced from their publichealth value.
Research funding contracts can help to safeguard against profound inequities in global allocation and distribution of lifesaving diagnostics, drugs, and vaccines. During large transnational publichealth crises, global demand soars for diagnostics, drugs, and vaccines. Using Contracts to Further Equity Goals.
During a recent Q&A, a representative with the WorldHealth Organization warned that the Omicron variant is not the last of its kind. Norton Rose Fulbright lawyers will continue to provide relevant updates for healthcare providers on the Health Law Pulse during the COVID-19publichealth crisis.
A little over one week later, we reported that the WorldHealth Organization declared a global health emergency after COVID-19 was detected in eighteen countries, infecting almost 10,000 people and killing more than two hundred. We have watched the United States declare a publichealth emergency.
The legal and institutional regime aimed at preventing and controlling the spread of infectious diseases, grounded on the International Health Regulations (IHR) was heavily criticized. The alarm mechanism based on the declaration of PublicHealth Emergency of International Concern (PHEIC), in particular, has been severely tested.
Health resources are unevenly distributed and often of poor quality. The WorldHealth Organization estimates that in the majority of African countries, there is one hospital per one million people, one doctor per 10,000 people and one hospital bed per 10,000 people.
Fielding calls from heads of state, they decided what vaccine deliveries to prioritize , shaping which countries could protect lives and livelihoods. The answer to one of the most important publichealth questions of our time — who gets access to vaccines? — Private decisions did not match publichealth need.
Brian Anderson, chief digital health physician at MITRE Corporation, and Bryant Karras, chief publichealth informatics officer and senior epidemiologist at Washington State Department of Health, will offer an update on the progress of the Vaccine Credential Initiative, and other initiatives like it.
Bard The White House is preparing to shut down their COVID Task Force this May, in conjunction with ending the publichealth emergency — the latest in a series of astounding and shortsighted decisions that put individual Americans at as great a risk from serious harm as a result of catching COVID-19 as at any stage in the pandemic.
With rising case numbers in across the DACH (Germany, Austria and Switzerland) region and the rest of Europe, a fully vaccinated status might become compulsory for the use of the EU Digital COVID Certificate (EUDCC) soon – at least in some countries. WHY IT MATTERS. THE LARGER TREND.
This week marks the two-year anniversary of WorldHealth Organization Director-General Tedros Adhanom declaring COVID-19 a pandemic. thus has reverberating repercussions: it strips away not only necessary publichealth precautions, but also hard-won adaptations, such as remote work and more generous sick leave policies.
On Friday, November 26, 2021, the WorldHealth Organization (“WHO”) reported a new variant of COVID-19, the Omicron variant, was detected in South Africa. There is no indication the new variant is more contagious or more lethal, or that it is resistant to the COVID-19vaccine.
G” through her publichealth-informed broadcasts in the Miami media market during the pandemic. The phenomenon of medical mis-information accelerated during the COVID-19 pandemic, normalizing weird anti-science and culminating in the rejection among many U.S. Health Populi’s Hot Points: U.S.
Monitoring the safe and effective use of medicines has now been an essential part of publichealth policy for several decades. The pharmacovigilance teams have played a vital role in the safe, effective, and rapid rollout of COVID-19vaccines and treatments. New advances in technology (e.g.,
Commission Extends Transparency and Authorization Mechanism for Exports of COVID-19Vaccines, 11 March 2021. The EC has extended until the end of June 2021 the transparency and authorization mechanism for COVID-19vaccine exports. The EU continues to be the leading provider of vaccines around the world.
By Anne Kjersti Befring and Cecilia Marcela Bailliet Introduction The COVID-19 pandemic posed a grave threat to humanity and revealed the need for a new approach to improve transnational cooperation within the global health system and new perspectives on solidarity addressing the cross-border spread of infection and distribution of vaccines.
An employee is considered “fully vaccinated” two weeks after completing primary vaccination with a COVID-19vaccine with, if applicable, at least the minimum interval between doses as recommended by the CDC, WorldHealth Organization (“WHO”), or if administered as a part of a clinical trial.
By María Natalia Echegoyemberry and Francisco Verbic This article looks at the COVID-19 pandemic response in Argentina, with a particular focus on the judicial control of publichealth policies. There, too, single judges decided on important social and health issues. SB/LC/JGI/VC 14056/2022).
We organize all of the trending information in your field so you don't have to. Join 26,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content